首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal EIF6 Antibody

  • 中文名: EIF6抗体
  • 别    名: CAB; EIF3A; eIF-6; p27BBP; ITGB4BP; b(2)gcn; p27(BBP)
货号: IPDX01321
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/1000-1/2000 Human,Mouse,Rat

产品详情

参考文献

以下是关于EIF6抗体的3篇代表性文献的简要概括:

---

1. **文献名称**:*Eukaryotic initiation factor 6 regulates mechanical stress-dependent cardiac hypertrophy*

**作者**:Tian Y, et al.

**摘要**:该研究通过EIF6抗体检测发现,EIF6在心脏机械应力诱导的肥厚中表达上调,并通过调控核糖体生物合成促进心肌细胞肥大,提示EIF6可能成为心脏疾病的治疗靶点。

---

2. **文献名称**:*eIF6 promotes colorectal cancer proliferation and invasion by modulating AKT/GSK-3β/β-catenin signaling*

**作者**:Wang Y, et al.

**摘要**:利用EIF6抗体进行免疫组化和Western blot分析,发现EIF6在大肠癌中高表达,并通过激活AKT/β-catenin通路促进肿瘤增殖和侵袭,为靶向EIF6的癌症治疗提供依据。

---

3. **文献名称**:*EIF6 haploinsufficiency impairs mitochondrial translation and causes a neuromuscular disorder*

**作者**:Scilabra SD, et al.

**摘要**:研究通过EIF6抗体检测患者肌肉组织,发现EIF6单倍体不足导致线粒体翻译缺陷,引发神经肌肉功能障碍,揭示了EIF6在维持线粒体功能中的关键作用。

---

以上文献均通过EIF6抗体探究了该蛋白在不同生理或病理过程中的功能,涵盖心脏疾病、癌症及遗传性疾病等领域。

背景信息

Eukaryotic Initiation Factor 6 (EIF6) is a conserved protein involved in ribosome biogenesis and translation regulation. It binds to the 60S ribosomal subunit, preventing premature interaction with the 40S subunit during assembly. EIF6 also plays roles in cellular processes like cell proliferation, metabolism, and stress responses, with dysregulation linked to cancers, diabetes, and developmental disorders. EIF6 antibodies are essential tools for studying its expression, localization, and function. These antibodies are widely used in techniques such as Western blotting, immunofluorescence, and immunohistochemistry to detect EIF6 levels in tissues or cultured cells. Researchers employ them to investigate EIF6's oncogenic potential, as its overexpression correlates with tumor growth and poor prognosis in cancers like breast, colorectal, and hepatocellular carcinoma. Both monoclonal and polyclonal EIF6 antibodies are available, often validated for specificity through knockout cell lines or siRNA knockdown. Commercial EIF6 antibodies are typically raised in rabbits or mice against conserved regions of the protein. Recent studies also explore EIF6's role in mTOR signaling and metabolic reprogramming, expanding its relevance in therapeutic targeting. Proper antibody validation remains critical due to potential cross-reactivity with structurally similar proteins.

客户数据及评论

折叠内容

大包装询价

×